200,000+ products from a single source!

sales@angenechem.com

Home > Oxazole > 20662-88-8

20662-88-8

20662-88-8 | Oxazole, 2-phenyl-

CAS No: 20662-88-8 Catalog No: AG002ILH MDL No:MFCD00461764

Product Description

Catalog Number:
AG002ILH
Chemical Name:
Oxazole, 2-phenyl-
CAS Number:
20662-88-8
Molecular Formula:
C9H7NO
Molecular Weight:
145.1580
MDL Number:
MFCD00461764
IUPAC Name:
2-phenyl-1,3-oxazole
InChI:
InChI=1S/C9H7NO/c1-2-4-8(5-3-1)9-10-6-7-11-9/h1-7H
InChI Key:
RQCBPOPQTLHDFC-UHFFFAOYSA-N
SMILES:
c1ccc(cc1)c1ncco1

Properties

Complexity:
121  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
145.053g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
145.161g/mol
Monoisotopic Mass:
145.053g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
26A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2  

Literature

Title Journal
Analysis of YM-216391 biosynthetic gene cluster and improvement of the cyclopeptide production in a heterologous host. ACS chemical biology 20120420
Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors. Bioorganic & medicinal chemistry letters 20111201
N-{2-[(4S)-4-tert-Butyl-4,5-dihydro-1,3-oxazol-2-yl]phen-yl}-5,6-diphenyl-1,2,4-triazin-3-amine. Acta crystallographica. Section E, Structure reports online 20110301
5-(4-Fluoro-phen-yl)-2-[2-(5-phenyl-1,3-oxazol-2-yl)phen-yl]-1,3-oxazole. Acta crystallographica. Section E, Structure reports online 20100901
Sulindac derivatives that activate the peroxisome proliferator-activated receptor gamma but lack cyclooxygenase inhibition. Journal of medicinal chemistry 20080828
Structure-activity studies on 1,3-dioxane-2-carboxylic acid derivatives, a novel class of subtype-selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonists. Bioorganic & medicinal chemistry 20080115
Conversion of human-selective PPARalpha agonists to human/mouse dual agonists: a molecular modeling analysis. Bioorganic & medicinal chemistry letters 20041220

© 2019 Angene International Limited. All rights Reserved.